Navigation Links
Merz, Inc. Announces Cynthia Schwalm as Vice President, Neurology
Date:9/17/2012

GREENSBORO, N.C., Sept. 17, 2012 /PRNewswire/ -- Merz, Inc. (U.S. affiliate of Merz Pharma Group) today announced the appointment of Cynthia Schwalm has as vice president, neurology effective immediately. Schwalm will be responsible for the Merz's growing neurology business unit in the U.S., which includes the recently acquired product CUVPOSA®.

"Cynthia brings national as well as international experience, in developing and commercializing pharmaceutical products. We are extremely pleased to have her join the Merz team and are confident she will make immediate and important contributions to steer the future growth of our neurology business and the company as a whole," said Bill Humphries, president & CEO of Merz, Inc.

Humphries noted that he will name his entire North American Leadership Team within the next few months as Merz, Inc. and its U.S. affiliates continue to undergo integration in preparation for accelerated growth opportunities across all business units.

Prior to joining Merz, Schwalm was the Senior Advisor to the Chief Executive Officer at Chimerix, Inc. She has held various international commercial leadership and general management positions with Optimer, Eisai, Amgen, and Johnson & Johnson. Schwalm brings with her 30 years of experience in the pharmaceutical and healthcare industry, with commercialization experience in movement disorders and neurology including pain management, Alzheimer's disease, and epilepsy including Lennox Gaustaut syndrome.

Schwalm obtained her Bachelor of Science in Nursing from the University of Delaware in Newark, DE. She also earned her Executive Master of Business Administration from the Wharton School of Business from the University in Pennsylvania in Philadelphia, PA. Schwalm is a member for Beth Abraham Family Health Services Board and Sarah Cannon Oncology Research Institute Board. She will be based out of the office in Greensboro, NC.

About Merz, Inc.

Merz, Inc. is responsible for developing and commercializing products in the U.S. for Merz Pharma Group. Areas of therapeutic focus include Neurology, Physiatry, Dermatology, Aesthetics, and Podiatry.

About Merz Pharma Group

Globally, the companies of Merz Pharma Group are focused on medications for treating neurological and psychiatric illnesses and thereby assume a leading role in the field of Alzheimer research.  Another important area of competency of Merz is Clinical Dermatology and Aesthetic Medicine. Merz is also active in the Health sector outside of the pharmacy. In the field of consumer products, with its established brands of tetesept® and Merz Spezial®, Merz Consumer Care is a leading provider of products for self-medication, nutritional supplements and skin care in the German-speaking area. Merz Pharma Group is a privately owned company, founded in 1908 in Frankfurt, Germany.


'/>"/>
SOURCE Merz, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Merz, Inc. Announces Promotion of Katrina Church to Vice President, Chief Compliance Officer
2. Heska Corporation Announces Amendment To Its Odd-Lot Tender Offer
3. Onconome Announces Results Of Blood Test For Colorectal Cancer; Further Trials Underway
4. Valeant Pharmaceuticals Announces Management Change
5. Neuralstem Announces Proposed Public Offering
6. PPCE Announces Strategic Partnership With ECLINSO AG
7. Agendia Announces Five Studies in Breast Cancer for Presentation at the American Society of Clinical Oncology 2012 Breast Cancer Symposium
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Soligenix Announces Issuance of US Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
10. Henry Schein Announces New $500 Million Credit Facility
11. BioDelivery Sciences Announces Positive Results of Pivotal Pharmacokinetic Study Comparing BEMA Buprenorphine/Naloxone (BNX) to Suboxone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology:
(Date:6/24/2016)... Brooklyn, New York (PRWEB) , ... June 24, 2016 , ... ... medical marijuana patients optimize the ingestion of their medication by matching users with high ... allows users to compare pieces with no commitment. , Inhale was founded by two ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Dr. Seema Daulat, ... Evans Dermatology in the South Lamar location as of July 13, 2016. , Dr. ... School. As a medical student, she regularly volunteered at the Agape Clinic serving Dallas’ ...
(Date:6/23/2016)... ... , ... An article published June 8 on AOL News describes ... cancer in individuals with unhealthy oral hygiene habits. The article goes on to state ... gum disease, brushed their teeth on a daily basis, wore dentures and if they ...
(Date:6/23/2016)... ... June 23, 2016 , ... The Mechille Wilson Agency, ... throughout Jasper County and the surrounding region, is initiating a charity drive to assist ... raise funds earmarked for a scholarship fund that will be presented to the chosen ...
(Date:6/23/2016)... ... ... Virginia Beach resident Sean Kelly suffered from depression after a long military career ... set out to accomplish a personal mission: a solo 50-mile paddle. Kelly decided to ... the story of another special operations veteran, Josh Collins, whom Kelly had served with ...
Breaking Medicine News(10 mins):